Overcoming chemotherapy-resistance in triple-negative breast cancer
Lupien, Mathieu
9 enregistrements totalisant 7,561,360.00 $ CAN, selon les données ouvertes officielles du gouvernement du Canada.
Intégrer ce graphique
Par ministère
| Instituts de recherche en santé du Canada | $7,561,360 | 9 enregistrements |
Enregistrements
The Project Grant program is expected to: • Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercia...
Delineating therapeutic opportunities in Triple-Negative Breast Cancer
Delineating the role of noncoding mutations in prostate cancer
The Project Grant program is expected to: • Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercia...
The Project Grant program is expected to: • Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercia...
Investigating the role of EZH2 genomic localization in the response to EZH2 inhibition in breast cancer subtypes
The epigenetics of genetics in cancer
The CIHR Institute of Gender and Health (CIHR-IGH) will fund applications that are relevant to its mandate and research priorities, as described in our new Research Priority Plan, and that are aligned...